Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road to acceptance.

Airways dysanapsis, a mismatch between airway calibre and lung volume, has long been observed as a physiological variant ...

With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...

Introduction Stroke is the second leading cause of death and disability creating a huge economic burden annually. Robot-assisted training (RT) is a promising therapy in stroke rehabilitation, but for ...

The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary ...

Real-world use of antifibrotic therapy is associated with greater estimated survival in pulmonary fibrosis interstitial lung disease (PF-ILD).

A blood test has achieved 96% accuracy in diagnosing the condition in a small study of individuals. What does the test detect ...

Diagnosis for myalgic encephalomyelitis/chronic fatigue syndrome currently relies on sometimes controversial diagnostic ...

Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose ...

Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.

The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease ...